[Form 4] Precigen, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Sunrun Inc. (RUN) – Form 144 filing: Director-level insider Paul S. Dickson has notified the SEC of a proposed sale of 8,010 common shares through Charles Schwab & Co. on or about 07 July 2025. The aggregate market value of the planned sale is $86,551, implying a reference price of roughly $10.80 per share. Sunrun reports 228.49 million shares outstanding, so the transaction represents less than 0.01 % of total shares.

The shares derive from a restricted-stock unit (RSU) lapse on the same date as the intended sale. During the prior three months, the filer sold 21,790 shares in two transactions (19,343 on 07 Apr 2025 and 2,447 on 06 Jun 2025) for combined gross proceeds of $150,587.

No 10b5-1 plan details or adverse information were disclosed. The filing is routine and does not change operational or financial guidance; however, it indicates continued insider disposition activity.

Positive

• Sale represents less than 0.01 % of shares outstanding, posing no dilution or liquidity impact on RUN’s float.

Negative

• Continued insider selling (total 29,800+ shares over four months) may be interpreted by some investors as a modest negative signal.

Insights

Financial Analyst

TL;DR – Small, routine insider sale; negligible dilution, neutral signal.

The 8,010-share sale (~$86k) equals <0.01 % of RUN’s float and follows two modest disposals earlier in the quarter. Such volumes are immaterial to liquidity or valuation. Insider selling can raise questions, but the RSU-related nature and limited size point to personal diversification rather than negative outlook. I see no impact on earnings, cash flow or strategic direction. Rating: neutral.

Corporate Governance Expert

TL;DR – Continues pattern of small RSU sales; governance risk minimal.

Dickson’s Form 144 aligns with typical executive compensation cycles. The representation clause states no undisclosed material information, and no regulatory red flags appear. Absence of a disclosed 10b5-1 plan reduces transparency slightly but is not mandatory. Overall governance implications are minor; investors should monitor cumulative insider trends rather than this single filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AGEE NANCY H

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/05/2025		M		126,760	A	(1)	176,836	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/05/2025		M			126,760	(2)	(2)	Common Stock	126,760	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

2. The RSUs vested in full on July 05, 2025.

	/s/ Nancy H. Agee, by Donald P. Lehr, as attorney-in-fact	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Sunrun (RUN) shares is Paul S. Dickson proposing to sell?

He plans to sell 8,010 common shares.

What is the estimated value of the proposed RUN share sale?

The aggregate market value reported is $86,551.

When is the planned sale date for the RUN shares?

The approximate sale date listed is 07 July 2025.

What percentage of Sunrun’s outstanding shares does the sale represent?

Less than 0.01 % of the outstanding 228.49 million shares.

Were other RUN shares sold recently by the same insider?

Yes, 21,790 shares were sold on 07 Apr 2025 and 06 Jun 2025 for $150,587 in gross proceeds.

Is the sale connected to a 10b5-1 trading plan?

The filing does not disclose adoption of a Rule 10b5-1 plan.